Biotech Co. Changes Name And Hires 1st Global IP Chief
Aeglea BioTherapeutics Inc. has added a trio of new officers to its C-suite, including its first global IP chief, and has changed its name to Spyre Therapeutics Inc., taking on the...To view the full article, register now.
Already a subscriber? Click here to view full article